loadpatents
Patent applications and USPTO patent grants for LOFTSSON; Thorsteinn.The latest application filed is for "preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery".
Patent | Date |
---|---|
Preparation Of Solid Cyclodextrin Complexes For Ophthalmic Active Pharmaceutical Ingredient Delivery App 20220008555 - LOFTSSON; Thorsteinn ;   et al. | 2022-01-13 |
Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery Grant 11,135,311 - Loftsson , et al. October 5, 2 | 2021-10-05 |
Free Fatty Acids And Methods Of Manufacture And Use For Treating Coronavirus And Other Viral Respiratory Infections App 20210290692 - STEFANSSON; Einar ;   et al. | 2021-09-23 |
Preparation Of Solid Cyclodextrin Complexes For Ophthalmic Active Pharmaceutical Ingredient Delivery App 20190343846 - LOFTSSON; Thorsteinn ;   et al. | 2019-11-14 |
Formation Of Cyclosporin A/cyclodextrin Nanoparticles App 20180161449 - LOFTSSON; Thorsteinn | 2018-06-14 |
Preparation Of Solid Cyclodextrin Complexes For Ophthalmic Active Pharmaceutical Ingredient Delivery App 20180147297 - LOFTSSON; Thorsteinn ;   et al. | 2018-05-31 |
Formation Of Cyclosporin A/cyclodextrin Nanoparticles App 20160346347 - LOFTSSON; Thorsteinn | 2016-12-01 |
Fatty acids for use as a medicament Grant 9,072,714 - Loftsson , et al. July 7, 2 | 2015-07-07 |
Cyclodextrin nanotechnology for ophthalmic drug delivery Grant 8,999,953 - Loftsson , et al. April 7, 2 | 2015-04-07 |
Coated Suppositories App 20140205650 - Loftsson; Thorsteinn | 2014-07-24 |
Cyclodextrin Nanotechnology For Ophthalmic Drug Delivery App 20140186443 - LOFTSSON; Thorsteinn ;   et al. | 2014-07-03 |
Cyclodextrin nanotechnology for ophthalmic drug delivery Grant 8,633,172 - Loftsson , et al. January 21, 2 | 2014-01-21 |
Cyclodextrin Nanotechnology For Ophthalmic Drug Delivery App 20130142791 - LOFTSSON; Thorsteinn ;   et al. | 2013-06-06 |
Fatty Acids For Use As A Medicament App 20130137771 - Loftsson; Thorsteinn ;   et al. | 2013-05-30 |
Fatty acids for use as a medicament Grant 8,372,425 - Loftsson , et al. February 12, 2 | 2013-02-12 |
Cyclodextrin Nanotechnology For Ophthalmic Drug Delivery App 20120028944 - Loftsson; Thorsteinn ;   et al. | 2012-02-02 |
Cyclodextrin nanotechnology for ophthalmic drug delivery Grant 7,893,040 - Loftsson , et al. February 22, 2 | 2011-02-22 |
Fatty Acids For Use As A Medicament App 20100113387 - Loftsson; Thorsteinn ;   et al. | 2010-05-06 |
Cyclodextrin nanotechnology for ophthalmic drug delivery App 20070020336 - Loftsson; Thorsteinn ;   et al. | 2007-01-25 |
Non-inclusion cyclodextrin complexes Grant 7,115,586 - Loftsson October 3, 2 | 2006-10-03 |
Method to improve complexation efficacy and produce high-energy cylodextrincomplexes App 20040242538 - Loftsson, Thorsteinn ;   et al. | 2004-12-02 |
High-energy cyclodextrin complexes App 20040186075 - Loftsson, Thorsteinn ;   et al. | 2004-09-23 |
Cyclodextrin complexes of benzodiazepines Grant 6,699,849 - Loftsson , et al. March 2, 2 | 2004-03-02 |
Non-inclusion cyclodextrin complexes App 20030109492 - Loftsson, Thorsteinn | 2003-06-12 |
Cyclodextrin complexation Grant 5,472,954 - Loftsson * December 5, 1 | 1995-12-05 |
Cyclodextrin/drug complexation Grant 5,324,718 - Loftsson June 28, 1 | 1994-06-28 |
Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol Grant 4,983,396 - Bodor , et al. January 8, 1 | 1991-01-08 |
Composition and method for enhancing permeability of topical drugs Grant 4,892,737 - Bodor , et al. January 9, 1 | 1990-01-09 |
Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol Grant 4,885,174 - Bodor , et al. December 5, 1 | 1989-12-05 |
Sulfur-substituted phenylacetamides Grant 4,859,707 - Loftsson , et al. August 22, 1 | 1989-08-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.